Latest News and Press Releases
Want to stay updated on the latest news?
-
Relay Therapeutics Announces Positive Interim Data for RLY-2608 Demonstrating Clinically Meaningful Progression Free Survival
-
Relay Therapeutics Announces Webcast to Report RLY-2608 Data on September 9, 2024
-
Relay Therapeutics Reports Second Quarter 2024 Financial Results and Corporate Highlights
-
Relay Therapeutics to Announce Second Quarter 2024 Financial Results and Corporate Highlights on August 6, 2024
-
Relay Therapeutics Discloses Three New Programs at New Program & Platform Event
-
CAMBRIDGE, Mass., June 05, 2024 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage precision medicine company transforming the drug discovery process by combining...
-
Relay Therapeutics to Participate in Upcoming Investor Conferences
-
Relay Therapeutics to Host New Program and Platform Event on June 6, 2024
-
Relay Therapeutics Reports First Quarter 2024 Financial Results and Corporate Highlights
-
Relay Therapeutics to Announce First Quarter 2024 Financial Results and Corporate Highlights on May 2, 2024